LY 2606368
Title | Journal |
---|---|
The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human Neuroblastoma. | Clinical cancer research : an official journal of the American Association for Cancer Research 20170801 |
LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms. | Molecular cancer therapeutics 20150901 |